$7.74
-0.55-6.63%
At close: -
$7.74
0.000.00%
After Hours: 4:22 PM EDT
Comments
Loading...
Stoke Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:STOK | Benzinga
Stoke Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 5
EPS Estimate
$-0.610
Quarterly Revenue Estimate
$2.83M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$36.55M
Analyze the earnings history of Stoke Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics | -$0.57 | -$0.61 | — | — | $4.22M | $2.83M | — | — | 05/05/2025 | Get Alert |
| STOK | Stoke Therapeutics | -$0.60 | -$0.54 | -$0.18 | 66.67% | $2.80M | $4.20M | $22.61M | 438.43% | 03/18/2025 | Get Alert |
| STOK | Stoke Therapeutics | -$0.55 | -$0.53 | -$0.47 | 11.32% | $3.31M | $3.35M | $4.89M | 46.09% | 11/05/2024 | Get Alert |
| STOK | Stoke Therapeutics | -$0.69 | -$0.55 | -$0.46 | 16.36% | -$2.48M | $3.41M | $4.83M | 41.67% | 08/07/2024 | Get Alert |
| STOK | Stoke Therapeutics | -$0.53 | -$0.61 | -$0.57 | 6.56% | $5.51M | $3.21M | $4.22M | 31.34% | 05/06/2024 | Get Alert |
| STOK | Stoke Therapeutics | -$0.65 | -$0.63 | -$0.60 | 4.76% | $3.27M | $3.25M | $2.80M | -13.82% | 03/25/2024 | Get Alert |
| STOK | Stoke Therapeutics | -$0.66 | -$0.63 | -$0.55 | 12.70% | $2.90M | $3.19M | $3.31M | 3.70% | 11/07/2023 | Get Alert |
| STOK | Stoke Therapeutics | -$0.63 | -$0.64 | -$0.69 | -7.81% | $3.23M | $3.44M | -$2.48M | -172.12% | 08/07/2023 | Get Alert |
| STOK | Stoke Therapeutics | -$0.66 | -$0.69 | -$0.53 | 23.19% | $3.00M | $3.00M | $5.51M | 83.73% | 05/04/2023 | Get Alert |
| STOK | Stoke Therapeutics | -$0.66 | -$0.70 | -$0.65 | 7.14% | $0.00 | $2.58M | $3.27M | 26.71% | 03/06/2023 | Get Alert |
| STOK | Stoke Therapeutics | -$0.61 | -$0.68 | -$0.66 | 2.94% | $0.00 | $2.45M | $2.90M | 18.57% | 11/14/2022 | Get Alert |
| STOK | Stoke Therapeutics | -$0.60 | -$0.71 | -$0.63 | 11.27% | $0.00 | $2.35M | $3.23M | 37.49% | 08/08/2022 | Get Alert |
| STOK | Stoke Therapeutics | -$0.46 | $0.36 | -$0.66 | -283.33% | $0.00 | $40.00M | $3.00M | -92.50% | 05/10/2022 | Get Alert |
| STOK | Stoke Therapeutics | -$0.42 | -$0.62 | -$0.66 | -6.45% | $0.00 | — | $0.00 | — | 03/10/2022 | Get Alert |
| STOK | Stoke Therapeutics | -$0.41 | -$0.59 | -$0.61 | -3.39% | $0.00 | — | $0.00 | — | 11/08/2021 | Get Alert |
| STOK | Stoke Therapeutics | -$0.39 | -$0.47 | -$0.60 | -27.66% | $0.00 | — | $0.00 | — | 08/10/2021 | Get Alert |
| STOK | Stoke Therapeutics | -$0.34 | -$0.46 | -$0.46 | 0.00% | $0.00 | — | $0.00 | — | 05/10/2021 | Get Alert |
| STOK | Stoke Therapeutics | -$0.09 | — | -$0.42 | — | $0.00 | — | $0.00 | — | 03/09/2021 | Get Alert |
| STOK | Stoke Therapeutics | -$0.26 | — | -$0.41 | — | $0.00 | — | $0.00 | — | 11/12/2020 | Get Alert |
| STOK | Stoke Therapeutics | -$1.54 | -$0.35 | -$0.39 | -11.43% | $0.00 | — | $0.00 | — | 08/10/2020 | Get Alert |
| STOK | Stoke Therapeutics | -$6.89 | — | -$0.34 | — | — | — | $0.00 | — | 05/15/2020 | Get Alert |
Stoke Therapeutics (STOK) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-18 | $-0.18 | $-0.54 | 66.7 % |
| Q3 | 2024-11-05 | $-0.47 | $-0.53 | 11.3 % |
| Q2 | 2024-08-07 | $-0.46 | $-0.55 | 16.4 % |
| Q1 | 2024-05-06 | $-0.57 | $-0.61 | 6.56 % |
Stoke Therapeutics (STOK) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-18 | $22.61M | $4.20M | 438.4 % |
| Q3 | 2024-11-05 | $4.89M | $3.35M | 46.1 % |
| Q2 | 2024-08-07 | $4.83M | $3.41M | 41.7 % |
| Q1 | 2024-05-06 | $4.22M | $3.21M | 31.3 % |
FAQ
When is Stoke Therapeutics (NASDAQ:STOK) reporting earnings?
Stoke Therapeutics (STOK) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on March 18, 2025 for Q4.
What were the latest earnings per share (EPS) for Stoke Therapeutics (NASDAQ:STOK)?
The Actual EPS was $-0.18, which beat the estimate of $-0.54.
What were Stoke Therapeutics’s (NASDAQ:STOK) revenues?
The Actual Revenue was $22.6M, which beat the estimate of $4.2M.
Browse earnings estimates, EPS, and revenue on all stocks.